TD Cowen analyst Tyler Van Buren reiterated a Buy rating on Tyra Biosciences (NASDAQ: TYRA)The analyst commented, "At Pharmachon, Tyra ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE